{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:09:28Z","timestamp":1762639768683,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.lfs.2006.08.028","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T07:22:19Z","timestamp":1157181739000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice"],"prefix":"10.1016","volume":"80","author":[{"given":"Shizuo","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Oki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2006.08.028_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Committee Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourology and Urodynamics"},{"issue":"4","key":"10.1016\/j.lfs.2006.08.028_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00003495-198835040-00006","article-title":"Current concepts in the treatment of disorders of micturition","volume":"35","author":"Andersson","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2006.08.028_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1569-9056(02)00045-3","article-title":"Potential benefits of muscarinic M3 receptor selectivity","volume":"Suppl. 1","author":"Andersson","year":"2002","journal-title":"European Urology"},{"issue":"2","key":"10.1016\/j.lfs.2006.08.028_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0022-3565(25)24446-9","article-title":"In vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency","volume":"272","author":"Beauchamp","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.lfs.2006.08.028_bib5","first-page":"1","article-title":"The overactive bladder","volume":"11","author":"Bulmer","year":"2000","journal-title":"Review of Contemporary Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.lfs.2006.08.028_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(93)90027-B","article-title":"Muscarinic receptor: characterization, coupling and function","volume":"58","author":"Caulfield","year":"1993","journal-title":"Pharmacology and Therapeutics"},{"issue":"4","key":"10.1016\/j.lfs.2006.08.028_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0165-6147(94)90047-7","article-title":"Muscarinic acetylcholine receptors in smooth muscles","volume":"15","author":"Eglen","year":"1994","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.lfs.2006.08.028_bib8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0022-3565(25)23162-7","article-title":"Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain","volume":"255","author":"Ehlert","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/j.lfs.2006.08.028_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0006-2952(96)00339-5","article-title":"Stimulation of cyclic AMP accumulation and phosphoinositide hydrolysis by M3 muscarinic receptors in the rat peripheral lung","volume":"52","author":"Esqueda","year":"1996","journal-title":"Biochemical Pharmacology"},{"issue":"19","key":"10.1016\/j.lfs.2006.08.028_bib10","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/0024-3205(88)90398-0","article-title":"Characterization of muscarinic receptor subtypes in human tissues","volume":"43","author":"Giraldo","year":"1988","journal-title":"Life Sciences"},{"key":"10.1016\/j.lfs.2006.08.028_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"6 Pt 1","key":"10.1016\/j.lfs.2006.08.028_bib12","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1097\/01.ju.0000138054.77785.4a","article-title":"Cystometric findings in mice lacking muscarinic M2 or M3 receptors","volume":"172","author":"Igawa","year":"2004","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1016\/j.lfs.2006.08.028_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-002-0554-x","article-title":"M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland","volume":"366","author":"Ikeda","year":"2002","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2006.08.028_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.lfs.2006.08.028_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-5793(88)80947-5","article-title":"Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes","volume":"239","author":"Maeda","year":"1988","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/j.lfs.2006.08.028_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-5347(05)00017-0","article-title":"Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder","volume":"175","author":"Maruyama","year":"2006","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1016\/j.lfs.2006.08.028_bib17","first-page":"L630","article-title":"Muscarinic receptor regulation of synaptic transmission in airway parasympathetic ganglia","volume":"270","author":"Myers","year":"1996","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.lfs.2006.08.028_bib18","series-title":"Proceedings of the 32nd Annual Meeting of the International Continence Society, Heidelberg, Germany","article-title":"Darifenacin is selective for the human recombinant M3 receptor subtype","author":"Napier","year":"2002"},{"issue":"24","key":"10.1016\/j.lfs.2006.08.028_bib19","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0024-3205(98)00495-0","article-title":"Ex vivo occupancy by tamslosin of \u03b11-adrenoceptors in rat tissues in relation to the plasma concentration","volume":"63","author":"Ohkura","year":"1998","journal-title":"Life Sciences"},{"issue":"5","key":"10.1016\/j.lfs.2006.08.028_bib21","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/01.ju.0000138472.16876.8d","article-title":"Demonstration of bladder-selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder","volume":"172","author":"Oki","year":"2004","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1016\/j.lfs.2006.08.028_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjp.0706184","article-title":"Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice","volume":"145","author":"Oki","year":"2005","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2006.08.028_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/jpet.105.094508","article-title":"Advantages for transdermal over oral oxybutynin to treat overactive bladder: muscarinic receptor binding, plasma drug concentration, and salivary secretion","volume":"316","author":"Oki","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"7","key":"10.1016\/j.lfs.2006.08.028_bib23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1368-5031.2005.00585.x","article-title":"Darifenacin in the treatment of overactive bladder","volume":"59","author":"Parsons","year":"2005","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.lfs.2006.08.028_bib24","first-page":"198P","article-title":"In vivo profile of darifenacin, a selective muscarinic M3 receptor antagonist","volume":"119","author":"Quinn","year":"1996","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.lfs.2006.08.028_bib25","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.64.6.1444","article-title":"Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice","volume":"64","author":"Struckmann","year":"2003","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.lfs.2006.08.028_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/1043-6618(95)86474-1","article-title":"Darifenacin, a selective muscarinic M3 antagonist","volume":"31S","author":"Wallis","year":"1995","journal-title":"Pharmacological Research"},{"issue":"2","key":"10.1016\/j.lfs.2006.08.028_bib27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0022-3565(25)09628-4","article-title":"Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins","volume":"273","author":"Wang","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.lfs.2006.08.028_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1532-5415.1990.tb03512.x","article-title":"Pharmacologic treatment of incontinence","volume":"38","author":"Wein","year":"1990","journal-title":"Journal of the American Geriatrics Society"},{"issue":"1","key":"10.1016\/j.lfs.2006.08.028_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0022-3565(25)32274-3","article-title":"Characterization of alpha-1 adrenergic receptor in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment","volume":"215","author":"Yamada","year":"1980","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.lfs.2006.08.028_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-3565(24)29676-2","article-title":"In vivo demonstration of \u03b1lA-adrenoceptor subtype selectivity of KMD-3213 in rat tissues","volume":"296","author":"Yamada","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"8","key":"10.1016\/j.lfs.2006.08.028_bib29","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.bjp.0705371","article-title":"In vitro and ex vivo effects of a selective nociceptin\/orphanin FQ (N\/FQ) peptide receptor antagonist, CompB, on specific binding of [3H]N\/FQ and [35S]GTP\u03b3S in rat brain and spinal cord","volume":"139","author":"Yamada","year":"2003","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.lfs.2006.08.028_bib32","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0022-5347(01)65752-5","article-title":"Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle","volume":"156","author":"Yamaguchi","year":"1996","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1016\/j.lfs.2006.08.028_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs and Aging"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506006722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320506006722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:06:56Z","timestamp":1758398816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320506006722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0024320506006722"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2006.08.028","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2006.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}